← FDA Drug Approvals (Drugs@FDA)
BREVICON 21-DAY
NDA · New Drug Application · Sponsor: ALLERGAN · Approved 1974-12-26
Drug application
- FDA Application #
NDA017566- Application type
- New Drug Application
- Brand name
- BREVICON 21-DAY
- Generic name
- Ethinyl Estradiol
- Active ingredients
- ETHINYL ESTRADIOL; NORETHINDRONE
- Dosage form
- TABLET
- Route
- ORAL-21
- Marketing status
- Discontinued
- Sponsor
- ALLERGAN
- First approval
- 1974-12-26
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown